PAGAN, ELEONORA
 Distribuzione geografica
Continente #
NA - Nord America 4.997
AS - Asia 4.902
EU - Europa 3.089
SA - Sud America 653
AF - Africa 103
OC - Oceania 18
Totale 13.762
Nazione #
US - Stati Uniti d'America 4.701
SG - Singapore 1.560
VN - Vietnam 1.161
IT - Italia 1.022
CN - Cina 724
DE - Germania 640
HK - Hong Kong 632
BR - Brasile 491
RU - Federazione Russa 426
SE - Svezia 252
CA - Canada 246
BD - Bangladesh 198
IE - Irlanda 177
FR - Francia 157
IN - India 136
ID - Indonesia 105
GB - Regno Unito 93
KR - Corea 70
AR - Argentina 67
FI - Finlandia 58
JP - Giappone 43
TR - Turchia 43
NL - Olanda 40
UA - Ucraina 39
PK - Pakistan 35
IQ - Iraq 34
AT - Austria 30
ZA - Sudafrica 29
EC - Ecuador 27
MX - Messico 26
ES - Italia 24
PL - Polonia 24
CH - Svizzera 23
DK - Danimarca 23
SA - Arabia Saudita 23
CO - Colombia 21
PH - Filippine 20
IR - Iran 16
AU - Australia 15
PY - Paraguay 14
TN - Tunisia 14
ET - Etiopia 12
MY - Malesia 12
RO - Romania 11
EG - Egitto 9
KE - Kenya 9
LB - Libano 9
PE - Perù 9
UZ - Uzbekistan 9
BG - Bulgaria 8
CL - Cile 8
CZ - Repubblica Ceca 8
TH - Thailandia 8
TW - Taiwan 8
VE - Venezuela 8
AE - Emirati Arabi Uniti 7
MA - Marocco 7
BO - Bolivia 6
GR - Grecia 6
IL - Israele 6
JM - Giamaica 6
JO - Giordania 6
KG - Kirghizistan 6
KZ - Kazakistan 6
BE - Belgio 5
DZ - Algeria 5
LT - Lituania 5
PS - Palestinian Territory 5
SN - Senegal 5
HN - Honduras 4
PR - Porto Rico 4
CR - Costa Rica 3
GE - Georgia 3
HR - Croazia 3
HU - Ungheria 3
MO - Macao, regione amministrativa speciale della Cina 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
RS - Serbia 3
AL - Albania 2
AM - Armenia 2
AO - Angola 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
GH - Ghana 2
NP - Nepal 2
OM - Oman 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
UG - Uganda 2
UY - Uruguay 2
AZ - Azerbaigian 1
BB - Barbados 1
BJ - Benin 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
CY - Cipro 1
EE - Estonia 1
LC - Santa Lucia 1
Totale 13.753
Città #
Ann Arbor 819
Singapore 800
Hong Kong 610
Frankfurt am Main 530
Ashburn 403
Ho Chi Minh City 337
San Jose 337
Milan 271
Fairfield 259
Hanoi 248
Wilmington 213
Toronto 196
Dublin 167
Dallas 159
Santa Clara 149
Houston 144
New York 143
Hefei 126
Chicago 122
Chandler 116
Los Angeles 110
Seattle 107
Beijing 100
Woodbridge 94
The Dalles 92
Princeton 89
Jakarta 86
Cambridge 78
Rome 69
Lauterbourg 61
Moscow 56
Dearborn 54
Dong Ket 49
Seoul 49
Altamura 45
Lawrence 43
Shanghai 43
San Diego 40
Helsinki 38
Guangzhou 35
Da Nang 34
Buffalo 32
Nanjing 32
Council Bluffs 31
Haiphong 31
Biên Hòa 30
São Paulo 29
Boardman 27
Ha Long 27
Munich 27
Naples 24
Tokyo 24
Nuremberg 23
Columbus 22
Warsaw 20
Turin 19
Hải Dương 18
Jacksonville 18
London 18
Thái Nguyên 18
Atlanta 17
Montreal 17
Sacramento 17
Zurich 17
Ardea 16
Quận Bình Thạnh 16
Mumbai 15
Dhaka 14
Andover 13
Chennai 13
Kent 13
Quận Một 13
Vienna 13
Bologna 12
Brooklyn 12
Lappeenranta 12
Monza 12
Orem 12
Rio de Janeiro 12
Seregno 12
Umeå 12
Baghdad 11
Carate Brianza 11
Hangzhou 11
Paris 11
Salt Lake City 11
Sesto San Giovanni 11
Addis Ababa 10
Belo Horizonte 10
Brasília 10
Brescia 10
Denver 10
Jeddah 10
Bắc Giang 9
Johannesburg 9
Ninh Bình 9
Pavia 9
Porto Alegre 9
Pune 9
Quito 9
Totale 8.470
Nome #
Joinpoint regression analysis with time-on-study as time-scale. Application to three Italian population-based cohort studies 609
Outcomes of patients with advanced solid tumors who discontinued immune-checkpoint inhibitors: a systematic review and meta-analysis 509
Laryngeal cancer mortality trends in European countries 376
Invasive Pleomorphic Lobular Carcinoma of the breast: Clinicopathological features, treatment patterns and outcomes 365
Male breast cancer: a multicenter study to provide a guide for proper management 348
Long-term outcome of invasive pure micropapillary breast cancer compared with invasive mixed micropapillary and invasive ductal breast cancer: a matched retrospective study 340
Efficacy and Limitations of Quinidine in Patients with Brugada Syndrome 307
Surrogate endpoints for overall survival in randomized clinical trials testing immune checkpoint inhibitors: a systematic review and meta-analysis 302
Sex-based differences of the Tumor mutational burden and T-cell inflammation of the tumor microenvironment 284
Fertility concerns, preservation strategies and quality of life in young women with breast cancer: Baseline results from an ongoing prospective cohort study in selected European Centers 280
Sentinel lymph node biopsy in microinvasive ductal carcinoma in situ 279
Pre-operative evaluation of epithelial ovarian cancer patients: Role of whole body diffusion weighted imaging MR and CT scans in the selection of patients suitable for primary debulking surgery. A single-centre study 271
Prognostic and predictive value of cell cycle progression (CCP) score in ductal carcinoma in situ of the breast 267
Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp-cooling system in early breast cancer patients treated with anthracyclines 263
Effectiveness of intensive clinical and radiological follow-up in patients with surgically resected NSCLC. Analysis of 2661 patients from the prospective MAGRIT trial 262
"Heterogeneity of treatment effect on patients' long-term outcome according to pathological response type in neoadjuvant RCTs for breast cancer." 260
Sex-Based Heterogeneity in Response to Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis 233
Evaluation of pathological complete response as surrogate endpoint in neoadjuvant randomised clinical trials of early stage breast cancer: systematic review and meta-analysis 222
Endocrine-responsive lobular carcinoma of the breast: Features associated with risk of late distant recurrence 219
Sex-based differences in cancer immunotherapy efficacy 219
Tailoring the optimal duration of the extended adjuvant endocrine therapy in patients with early-stage breast cancer. A systematic review and meta-analysis of randomized clinical trials 214
Employment trajectories of young women with breast cancer: an ongoing prospective cohort study in Italy and Switzerland 213
Surrogate End Points for Overall Survival in Neoadjuvant Randomized Clinical Trials for Early Breast Cancer 211
Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome 210
Metronomic Chemotherapy for First-Line Treatment of Metastatic Triple-Negative Breast Cancer: A Phase II Trial 207
Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1 205
Reply to Comments on: “Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp cooling system in early breast cancer patients treated with anthracyclines.” 202
Shifting from axillary dissection to targeted axillary surgery after neoadjuvant treatment: the evolving management of occult breast cancer in a monoinstitutional series of 114 patients 200
Assessment of absolute risk of life-threatening cardiac events in long QT syndrome patients 196
Long-term standard sentinel node biopsy after neoadjuvant treatment in breast cancer: a single institution ten-year follow-up 194
Association of prebiotic fiber intake with colorectal cancer risk: the PrebiotiCa study 193
Diagnostic performance of image-guided vacuum-assisted breast biopsy after neoadjuvant therapy for breast cancer: prospective pilot study 189
Surrogate endpoints for overall survival in randomized clinical trials testing antibody-drug conjugates 185
Comparative Efficacy of Classic Versus Horizontal Incision Techniques in Skin-Reducing Mastectomy: A Single Center Retrospective Analysis 182
Development and Validation of a Natural Language Processing Algorithm for Extracting Clinical and Pathological Features of Breast Cancer From Pathology Reports 182
The prolonged clinical benefit with metronomic chemotherapy (VEX regimen) in metastatic breast cancer patients 182
Sex-based dimorphism of anticancer immune response and molecular mechanisms of immune evasion 181
Prognosis of selected triple negative apocrine breast cancer patients who did not receive adjuvant chemotherapy 180
Results of the Italian cross-sectional web-based survey “Nutrition and breast cancer, what would you like to know?” An attempt to collect and respond to patients’ information needs, through social media 176
Multicomponent interventions and technologies to reduce the burden of frailty, functional, and cognitive decline: insights from the Age-It Research Program 172
Epidermal growth factor receptor detection in serum and saliva as a diagnostic and prognostic tool in oral cancer 170
Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy 168
Factors influencing 5-year persistence to adjuvant endocrine therapy in young women with breast cancer 166
Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome 166
Different Response to Immunotherapy According to Melanoma Histologic Subtype 164
Evaluation of endocrine therapy and patients preferences in early breast cancer: results of Elena study 163
Does failed mapping predict sentinel lymph node metastasis in cN0 breast cancer? 159
Prognostic impact of baseline immunologic profile in aggressive b-cell non-hodgkin's lymphomas 155
Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk) 152
Value of 3D echocardiography in the diagnosis of arrhythmogenic right ventricular cardiomyopathy 150
Intra- inter-observer repeatability in liver computed tomography volumetry in patients undergoing radioembolization simulation 147
How to Perform Repeat Sentinel Node Biopsy Safely After a Previous Mastectomy: Technical Features and Oncologic Outcomes 145
How Useful Are Tumor Markers in Detecting Metastases with FDG-PET/CT during Breast Cancer Surveillance? 141
Oncoplastic Breast-Conserving Surgery for Synchronous Multicentric and Multifocal Tumors: Is It Oncologically Safe? A Retrospective Matched-Cohort Analysis 136
Pegylated liposomal doxorubicin (Caelyx®) as adjuvant treatment in early-stage luminal b-like breast cancer: A feasibility phase II trial 136
Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterations 127
Ductal carcinoma in situ of the male breast: clinical radiological features and management in a cancer referral center 123
Systematic review and meta-analysis of post-progression outcomes in ER+/HER2− metastatic breast cancer after CDK4/6 inhibitors within randomized clinical trials 123
Improved outcomes in women with BRAF-mutant melanoma treated with BRAF/MEK-targeted therapy across randomized clinical trials. A systematic review and meta-analysis 122
Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk): comment - Authors' reply 122
Sex-based differences in response to anti-PD-1 or PD-L1 treatment in patients with non-small-cell lung cancer expressing high PD-L1 levels. A systematic review and meta-analysis of randomized clinical trials 119
Improved outcomes in women with BRAF-mutant melanoma treated with BRAF/MEK-targeted therapy across randomized clinical trials. A systematic review and meta-analysis 114
Outcome of patients with metastatic triple negative breast cancer treated with first-line chemotherapy: a single institution retrospective analysis 113
Adjuvant treatment for triple negative breast cancer with residual tumor after neo-adjuvant chemotherapy. A single institutional retrospective analysis 111
Heterogeneity of progression-free survival surrogacy by sex in randomized trials testing immunotherapy in non-small cell lung cancer 104
Comparison of Trends in Mortality from Coronary Heart and Cerebrovascular Diseases in North and South America: 1980 to 2013 104
Outcomes, indications and predictive factors for complications in postmastectomy prepectoral reconstructions with polyurethane foam-coated implants 97
Ten-year outcome results of cT4 breast cancer after neoadjuvant treatment 95
One-Year Mortality in Hospitalized, Frail Older Adults with Atrial Fibrillation on Oral Anticoagulant Therapy: Impact of Stroke and Bleeding Events 90
Distant disease-free survival as a surrogate endpoint for overall survival in randomised trials of neoadjuvant therapy for early breast cancer: a pooled analysis of GBG and AGO-B Study Group trials 70
Extended Endocrine Therapy Following 5 Years of Adjuvant Luteinizing Hormone-Releasing Hormone Agonist in Premenopausal Patients With Node-Positive, Hormone Receptor–Positive Breast Cancer: A Cohort Study 69
Effect of a Multimedia-Assisted Informed Consent Procedure on the Information Gain of Patients Undergoing Mastectomy and Implant-Based Reconstruction 59
Effects of multidomain interventions on health outcomes in older adults: A systematic review and meta-analysis 25
Totale 14.194
Categoria #
all - tutte 47.906
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.906


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021182 0 0 0 0 0 0 0 0 0 0 0 182
2021/2022742 81 52 63 33 24 72 33 45 46 79 70 144
2022/20231.251 149 352 172 105 102 185 29 34 24 34 32 33
2023/2024776 18 15 29 72 79 158 106 46 72 40 31 110
2024/20252.649 129 306 135 132 159 138 164 93 296 329 307 461
2025/20266.644 846 772 520 575 544 261 818 325 437 521 511 514
Totale 14.194